6.6 million people in the US and 50 million worldwide have Alzheimer’s disease in 2025
Alzheimer’s patient should plan for the future including legal, financial, and long-term care
Alzheimer International Society™ is a non-profit organization with the goal to facilitate and accelerate the research to find prevention and treatment therapeutics for Alzheimer’s disease, and to provide services and support to our stakeholders around the world.
Today there are more than 6 million people in the US and 50 million people around the world have suffered from Alzheimer’s disease.
Learn moreThe ASIC 2026 will highlight the latest accomplishment in
Alzheimer research and patient care. ASIC 2026 encourages new concepts and hypotheses on the etiology and potential prevention or treatment therapy. New ideas and alternatives to Amyloid cascade hypothesis such as Tau hypothesis, Calcium hypothesis, Inflammation hypothesis, Cholinergic and Oxidative stress hypothesis, Neurogenesis Hypothesis and other new ideas with supporting data are welcome at the ASIC.
The Alzheimer's Drug Development Symposium (ADDS) 2026 will be held in conjunction with the Alzheimer Society International Congress, May 18-20, 2026 in San Francisco.
Alzheimer International Society™ is a professional international society for individuals interested in Alzheimer's and dementia science. Be a part of an international network of researchers, scientists, and healthcare providers with common interests in various Professional Focused Areas (PFAs)
Learn more
In the early onset of the Alzheimer’s disease, most patients may can live relatively a normal life. However, the loved ones recognize that the patient has increasing incidence of memory lapses and fails to recognize familiar faces and things around them. In addition, the patient tends to lose the sense
Learn more
The Alzheimer International Society™ is dedicated to foster the global effort to end Alzheimer's disease. The Society serves as the coordinating hub to interconnect with scientific, academic, government and industry thought-leaders and key stakeholders worldwide
Learn more
There will be 3 workshops on May 18, 2026 5 on important pre-clinical and clinical aspects of drug therapeutics for the prevention and treatment of Alzheimer's disease. (details will be announced shortly)
Workshop Registration
The Alzheimer Society International Congress™ will be held on May 18- 20, 2026 in San Francisco .
The preliminary conference schedule has been posted online:
Learn more
Early-bird registration will end on January 30, 2026
Regular registration will be from February 1 to May 15, 2026
On-site registration rates will be applied from May 15-20, 2026
Learn more